He et al. [10] reported that LY2109761 in combination with transcatheter arterial chemoembolization reduced liver tumor size and metastases in a Smad2-dependent manner in both a rabbit tumor model and an HCC model [10]. Here, SMAD2 is linked to hepatocellular carcinoma.